Sarepta Therapeutics, Inc. (SRPT)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance

Current Price

as of Jan 07, 2025

$124.49

P/E Ratio

103.41

Market Cap

$11.89B

Description

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Metrics

Overview

  • HQCambridge, MA
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerSRPT
  • Price$124.49-2.66%

Trading Information

  • Market cap$11.89B
  • Float93.75%
  • Average Daily Volume (1m)646,254
  • Average Daily Volume (3m)926,354
  • EPS$1.29

Company

  • Revenue$1.64B
  • Rev growth (1yr)40.79%
  • Net income$33.61M
  • Gross margin78.27%
  • EBITDA margin7.78%
  • EBITDA$36.33M
  • EV$12.74B
  • EV/Revenue7.77
  • P/E103.41
  • P/S7.62
  • P/B9.74
Documents